Tilray, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The firm is engaged in cannabis research, cultivation, processing and distribution, offering a wide range of branded products in over 20 countries, including various cannabis products, hemp-based foods, and alcoholic beverages. The firm was founded in 2013 and is headquartered in Nanaimo, Canada. The company is focused on production of medical cannabis and cannabinoids. Tilray was the first licensed producer of medical cannabis in the world to be certified in accordance with European Medicine Agency (EMA) standards and was the first firm to legally export medical cannabis from North America to Europe, Australia and New Zealand. The firm offers adult-use, medical and bulk sales of cannabis under regulated licenses and the company’s products are sold to retail and wholesale outlets, pharmacies and direct to consumers. The firm also sells hemp seeds, hemp foods, and board spectrum hemp extract containing CBD, which are sold via retail and wholesale outlets and direct to consumers. The company trades on the NASDAQ where it is listed under the ticker TLRY. To receive updates on the TLRY share price, add this stock to your eToro watchlist.